share_log

Heart Test Laboratories | 424B3: Prospectus

Heart Test Laboratories | 424B3: Prospectus

Heart Test Laboratories | 424B3：募资说明书
美股SEC公告 ·  03/18 06:09

Moomoo AI 已提取核心信息

Heart Test Laboratories, Inc. (HeartSciences) has filed a prospectus with the SEC for the resale of up to 34,684,859 shares of common stock by selling stockholders. The shares include 4,854,853 shares issued to Icahn School of Medicine at Mount Sinai (Mount Sinai) and additional shares issuable upon exercise of warrants. The company is also registering shares that may be sold to Lincoln Park Capital Fund, LLC (Lincoln Park) under a purchase agreement. HeartSciences will not receive proceeds from the selling stockholders, except from any cash exercise of warrants. Proceeds from sales to Lincoln Park will be used for working capital and general corporate purposes. The company's common stock and warrants are listed on the Nasdaq Capital Market under the symbols 'HSCS' and 'HSCSW,' respectively. The filing includes provisions that may deter hostile takeovers or changes in control or management.
Heart Test Laboratories, Inc. (HeartSciences) has filed a prospectus with the SEC for the resale of up to 34,684,859 shares of common stock by selling stockholders. The shares include 4,854,853 shares issued to Icahn School of Medicine at Mount Sinai (Mount Sinai) and additional shares issuable upon exercise of warrants. The company is also registering shares that may be sold to Lincoln Park Capital Fund, LLC (Lincoln Park) under a purchase agreement. HeartSciences will not receive proceeds from the selling stockholders, except from any cash exercise of warrants. Proceeds from sales to Lincoln Park will be used for working capital and general corporate purposes. The company's common stock and warrants are listed on the Nasdaq Capital Market under the symbols 'HSCS' and 'HSCSW,' respectively. The filing includes provisions that may deter hostile takeovers or changes in control or management.
心脏测试实验室有限公司（HeartSciences）已向美国证券交易委员会提交了招股说明书，要求通过出售股东转售多达34,684,859股普通股。这些股票包括向西奈山（西奈山）伊坎医学院发行的4,854,853股股票，以及行使认股权证后可发行的额外股票。该公司还注册了可能根据购买协议出售给林肯公园资本基金有限责任公司（林肯公园）的股份。HeartSciences不会从出售股东那里获得收益，除非从认股权证的现金行使中获得收益。向林肯公园出售的收益将用于营运资金和一般公司用途。该公司的普通股和认股权证分别在纳斯达克资本市场上市，代码分别为 “HSCS” 和 “HSCSW”。该文件包括可能阻止敌对收购或控制权或管理变更的条款。
心脏测试实验室有限公司（HeartSciences）已向美国证券交易委员会提交了招股说明书，要求通过出售股东转售多达34,684,859股普通股。这些股票包括向西奈山（西奈山）伊坎医学院发行的4,854,853股股票，以及行使认股权证后可发行的额外股票。该公司还注册了可能根据购买协议出售给林肯公园资本基金有限责任公司（林肯公园）的股份。HeartSciences不会从出售股东那里获得收益，除非从认股权证的现金行使中获得收益。向林肯公园出售的收益将用于营运资金和一般公司用途。该公司的普通股和认股权证分别在纳斯达克资本市场上市，代码分别为 “HSCS” 和 “HSCSW”。该文件包括可能阻止敌对收购或控制权或管理变更的条款。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间